Tuberculosis remains a significant public health problem: one-third of the human population is infected with virulent Mycobacterium tuberculosis (MTB) and 10% of those are at risk of developing tuberculosis during their lifetime. In both humans and experimental animal models, genetic variation among infected individuals contributes to the outcome of infection. However, in immunocompetent individuals (the majority of patients), genetic determinants of susceptibility to tuberculosis remain largely unknown. Mouse models of MTB infection, allowing control of exposure and other potential environmental contributors, have proven extremely useful for examining this genetic component. In a cross of C3HeB/FeJ (susceptible) by C57BL/6J (resistant) inbred mouse strains, we have previously identified one major genetic locus, sst1, the susceptible allele of which did not confer an overt immunodeficiency, but rather specifically affected progression of lung tuberculosis. Having generated and tested the sst1 congenic strains, we have observed that this locus only partially explained the difference in susceptibility of the parental strains to MTB. We now present further studies controlling for the effect of the sst1, identify four additional tuberculosis susceptibility loci and characterize their effects by testing an independent cross, knockout or congenic mice.
Introduction
Tuberculosis remains a significant public health problem: one-third of the human population is infected with virulent Mycobacterium tuberculosis (MTB) and 10% of those are at risk of developing tuberculosis during their lifetime. 1 Existence of effective mechanisms of host resistance to tuberculosis is demonstrated by the fact that a significant proportion of individuals who have been exposed to virulent MTB remain disease-free. At present, an understanding of how MTB deceives and defeats the immune system, and thus the ability to predict which individuals and populations are at risk and to develop directed therapeutic interventions, is lacking.
In both humans and experimental animal models, genetic variation among infected individuals contributes to the outcome of infection. [2] [3] [4] [5] [6] [7] Mutations that disrupt an essential pathway of host resistance, such as Th1-mediated immunity (reviewed in Casanova and Abel, 2 and North and Jung 8 ), confer a high degree of susceptibility to mycobacterial infection both in humans and mice. In those cases, high degree of susceptibility can be explained by mutation in a single gene and is inherited as a Mendelian disorder. These mutations usually confer susceptibility to broad range of mycobacterial species, including normally non-pathogenic mycobacteria, as a result of severe defects in immunity and, therefore, are rare in natural populations. However, in immunocompetent individuals, genetic determinants of susceptibility to tuberculosis remain largely unknown. The majority of patients that suffer from tuberculosis, however, have no overt immunodeficiency and their susceptibility is likely to be due to combinatorial effects of multiple genetic and environmental factors. Furthermore, the evolutionary success of M. tuberculosis is ensured by its ability to thrive in hosts with overall normal immune function, suggesting subtle, rather than significant, alterations of the immune system will explain much of the variability of response in host populations.
Mice provide an excellent model system to explore the relationship between genetic variation in host populations and infection outcome. The ability to control environmental exposure and to manipulate genomes affords obvious experimental potential not available in direct human studies and, in addition, many classical inbred strains are known to have extreme susceptibility and resistance. Among classical inbred strains, the C57BL/6J (B6) mice have been repeatedly observed to be among the most resistant to tuberculosis. 4, 6, 7, 9 By contrast, the C3HeB/FeJ (C3H) mouse strain was noted for dramatic lung pathology that develops within 3-4 weeks after intravenous (i.v.) infection with 10 5 CFU of virulent MTB and rapid death. [10] [11] [12] Using this model of infection with virulent M. tuberculosis, we have previously identified one genetic locus (sst1), at which the susceptible polymorphic allele did not confer an overt immunodeficiency, but rather specifically affected progression of lung tuberculosis. 13 We have identified a candidate gene, Intracellular pathogen resistance 1 (Ipr1), within the sst1 locus 14 and have demonstrated that the C3HeB/FeJ substrain that we used as a susceptible parental strain in our crosses, carries a unique allele at the sst1 locus, which is distinct from three other substrains of the C3H mice, such as C3H/HeSnJ, C3H/HeJ and C3H/ HeOuJ. This is a novel mutation, which leads to lack of expression of the Ipr1 gene in C3HeB/FeJ substrain and confer an extreme susceptibility to tuberculosis as compared to other, more resistant, substrains of C3H. 14 The Ipr1 gene was shown to control macrophagemediated mechanism of innate immunity to at least two intracellular pathogens, MTB and Listeria monocytogenes, and did not affect resistance to avirulent M. bovis BCG, 13, 14 which is known to be controlled by the Nramp1 gene. 15 Analysis of the tuberculosis resistance of the sst1-congenic mice that we have generated, demonstrates that, although the sst1 locus is a very important determinant of innate immunity to MTB, its effect only partially explains the difference in tuberculosis resistance of the two parental strains, which have been used in our studies. We now present further studies controlling for the effect of sst1, identify four additional tuberculosis susceptibility loci and confirm the effect of each by knockout or an independent cross.
Results and discussion
The sst1 congenic strain C3H.B6-sst1 was generated by transferring an approximately 25 cM segment encompassing the sst1 locus (containing the Ipr1 gene) from C57BL/6J (henceforth B6 -carrier of the resistant, wildtype allele at Ipr1) on the C3HeB/FeJ (henceforth C3H -carrier of the susceptible allele of the sst1 locus that does not express the full-length Ipr1) genetic background (Table 1) . After backcross 2, the congenic interval transferred from the B6 resistant background did not include the Slc11a1 gene (formerly known as Nramp1), which is located at 39.2 cM, proximal to D1Mit7 (Table 1) , and, therefore, all the backcross progeny were homozygous for the C3H-derived resistant allele of the Nramp1 gene, but segregated at a closely linked sst1 locus. In each backcross, 30-50 progeny were tested for co-segregation of microsatellite markers flanking the sst1 region on chromosome 1 with time to death (TTD) after i.v. infection with 10 5 CFU of MTB ( Table 1 ). The survival time of the sst1 heterozygous progeny was significantly higher than that of their littermates, which were homozygous for the susceptible allele at the sst1 locus (Po0.001, for example, see backcross 3 in Table 1 ). The B6-derived resistant allele of the sst1 (sst1 R ) controlled survival after tuberculosis infection in a dominant fashion, since the heterozygotes (r/s) and the sst1-resistant homozygotes (r/r) were quantitatively indistinguishable. The B6.C3H-sst1 congenic strain was generated by transferring approximately 12 cM interval from C3HeB/FeJ on the B6 background using 10 backcrosses (Table 2) .
Both sst1 congenic pairs on the B6 and C3H genetic backgrounds were compared for their susceptibility to systemic i.v. and aerosol infection with MTB. Substitution of the sst1 allele affected tuberculosis susceptibility of mice on both genetic backgrounds (Table 2) . Comparing the survival of pairs of strains that carry identical sst1 allele (B6 with C3H.B6-sst1, or B6.C3H-sst1 with C3H) demonstrates the substantial effect of distinct, yet unknown, genetic loci. In order to most powerfully detect the non-sst1 loci involved in resistance, we opted to design a cross in which the phenotypic variance due to sst1 was removed. To accomplish this, we have generated (C3H.B6-sst1 Â B6) F2 hybrids, thus fixing the sst1 resistant allele as homozygous in all animals. In two independent experiments, a total of 360 (C3H.B6-sst1 Â B6) F2 hybrids were infected intravenously with 1 Â 10 5 CFU of MTB per mouse. The survival curves of the F2 hybrid mice obtained in two independent experiments were remarkably similar ( Figure 1b ) and, therefore, were combined for the analysis. In both experiments about 10% of the mice succumbed to MTB before 70 days postinfection, while 22-25% of the F2 hybrids survived for more than 140 days (Figure 1a , solid line). At 280 days, the surviving mice were killed to confirm tuberculosis infection. MTB was detectable in the lungs of all examined mice indicating that their extended survival was not a result of experimental error.
In a separate experiment, we tested the (C3H Â B6.C3H-sst1)F2 hybrids obtained by crossing of two sst1 susceptible strains C3H and B6.C3H-sst1 (Table 1) , all of which were homozygous for the sst1-susceptible allele (Figure 1a , dashed line). Out of 244 F2 mice infected intravenously with the same dose of MTB, only 29 animals (12.4%) survived more than 42 days after infection, while the majority of the mice (87.6%) succumbed to the infection within 30 days (MST ¼ 27 days), similar to the survival of the C3HeB/FeJ parental strain. Comparison of the phenotypic distribution in the two F2 populations demonstrated that the sst1 locus did play a major role in determining survival of the MTBinfected F2 mice. Furthermore, it was clear that the cross that used the two sst1 resistant strains to eliminate sst1 variation (B6 and C3H.B6-sst1) had a greater phenotypic variance and would likely enable mapping of additional loci more easily.
It was noted that the (C3H.B6-sst1 Â B6)F2 female mice lived considerably longer after infection than their male littermates (Figure 1d ). Noting a mean difference of 20 days survival, we subtracted 20 days from each female survival time and noted that upon correction, the distributions of male and female survival times were indistinguishable (Wilcoxon rank-sum test not significant) and the overall variance had been considerably lowered. For the purposes of the autosomal genome scan, we use this corrected survival time as our phenotype. No significant linkage to the X chromosome was found in either F2 males or females, when analyzed independently, indicating that the sex difference was not due to polymorphic genes on X chromosome, but might have been due to the influence of sex hormones, or some other sex-dependent factors. The removal of this additional variance should enhance the signal due to autosomal genes; however, it is worth noting that a retrospective analysis of the uncorrected survival times did not change the findings of significant linkage for the four loci described below.
Initially, a whole genome scan was performed on individuals that represented phenotypic extremes in the sst1-resistant (C3H.B6-sst1 Â B6)F2 population. A set of 130 microsatellite markers that cover all 19 autosomes of the mouse genome at approximately 10 cM intervals was used to genotype the most susceptible animals that survived for less than 12 weeks (84 days) after infection (n ¼ 86) and the most resistant mice that survived for more than 168 days (n ¼ 77), representing in both cases approximately 20% of the total population.
Eight regions reaching suggestive or significant linkage or having inadequate marker coverage in the initial scan were selected for additional evaluation (Supplementary Table 1 ). In these regions, we added additional markers (roughly doubling the density of markers) and included the genotyping of the remaining 60% of the phenotypic distribution for these markers. Linkage to chromosomes 7, 12, 15 and 17 exceeded the LanderKruglyak dense map thresholds for significance (logarithm of odds (LOD)44.2) ( Table 3) when linkage was evaluated either with a robust nonparametric statistics 16 or with a newly introduced LOD score based on the Cox proportional-hazards model. 17 Chromosome 12 locus Interestingly, but not unusual given the apparent polygenic architecture described here, it was the susceptible parental strain C3H that contributed the MTB-resistance allele of the chromosome 12 locus. As shown in Figure 2a , mice homozygous for the C3H-derived allele had significant advantage in survival as compared to the B6-allele homozygous and heterozygous animals (Po0.0001). The maximum linkage observed is telomeric to the most distal marker typed (D12Mit263) and is closely linked to the mouse immunoglobulin heavy chain (Igh) locus, a critical gene cluster for B lymphocyte maturation and function. The Igh locus is known to be polymorphic between the B6 and C3H parental strains. 18 This locus clearly differs ancestrally between these strains based on whole-genome shotgun sequence comparison. 19 To directly assess the importance of the immunoglobulin genes in our model of tuberculosis infection, we used Igh knockout mice, which lack mature B-cells and produce no immunoglobulins 20 ( Figure 2b and c, respectively). On two different genetic backgrounds ablation of the B cell function did not confer extreme susceptibility to tuberculosis (exemplified by rapid death of IL-12 knockout mice in Figure 2b) ; rather, there was a statistically significant shortening of survival in the B cell-deficient mice as compared to wild-type controls. This experiment demonstrates that although the magnitude of effects of IgH on tuberculosis resistance is much weaker as compared to an essential role of IL-12, it is significant in immunocompetent hosts. Our data implicate B lymphocytes in control of intracellular pathogen M. tuberculosis, suggesting that functional genetic polymorphisms within the immunoglobulin heavy chain locus may affect host resistance to tuberculosis.
The Igh locus is an especially attractive candidate as the role of antibody-mediated humoral immune response in protection against MTB remains incompletely understood. [21] [22] [23] [24] Several studies have demonstrated that the spectrum of specificities of antimycobacterial antibodies was much narrower in B6 and B10 inbred mice as compared to several other inbred strains. 25, 26 These differences were observed after infection with live MTB and BCG as well as after immunization with antigenic preparations of mycobacteria. However, this well-established deficiency in B6 response to mycobacterial antigens has not previously been directly associated to host susceptibility. B lymphocytes have been recently shown to play a role in resistance to intracellular pathogens that is distinct from their antibody-producing function. 23, 27 Previously, the IgH b allotype has been associated with anergy and pulmonary granulomatous inflammation early after systemic injection of M. bovis BCG. 28, 29 To start addressing B cell function in our model, we compared B lymphocytes in tuberculosis lung lesions in the parental B6 and C3H.B6-sst1 mice. Using FACS analysis, we observed that tuberculosis lung lesions of B6 mice contained significantly more B lymphocytes (8-12%) as compared to 2-3% in the lungs of C3H.B6-sst1 mice (Po0.001). In B6 mice, B cells formed large globular clusters occupying significant areas of inflammatory lung lesions. The B cell clusters were substantially smaller in the lungs of the C3H.B6-sst1 mice (Supplementary Figure 1 ). These data demonstrate that B cell function is genetically controlled in our strain combination and is relevant for shaping tuberculosis lung lesions. However, further studies are required to determine whether the polymorphism at the chromosome 12 locus affects the development of MTB-specific B cells, their migration into the tuberculosis lung lesions, or their Interval listed contains the maximum score and contains the entire continuous region where the non-parametric score exceeds 3.5 -this score corresponding to the approximate level at which linkage is expected once per genome scan by chance. In each case, these intervals constitute a conservative 1.5 LOD dropoff around the survival LOD peak as well.
ability to produce MTB-specific antibodies. The difference in B cell numbers in the tuberculosis lung lesions of B6 and C3H.B6-sst1 mice that we have observed, as well as differences in the spectrum of mycobacteria-specific antibodies reported by others, may be functionally and genetically linked or may be controlled independently.
To definitively determine which tuberculosis susceptibility locus controls which B cell function in our model, pairs of congenic mice for each tuberculosis susceptibility locus will have to be tested. Nevertheless, our data indicate that B cells do play a role in control of MTB infection and establishes the Igh gene cluster as a strong candidate for chromosome 12 locus.
Chromosome 17 locus
Tuberculosis resistance locus on chromosome 17 had a peak overlapping with the immunologically important and highly polymorphic mouse major histocompatibility complex (MHC). Association of tuberculosis susceptibility with MHC polymorphisms have been previously reported both in humans 30 and in a mouse model of infection. 31, 32 In mice, different alleles at specific H-2 loci affected survival after i.v. infection with virulent MTB, the level of delayed type hypersensitivity (DTH), T cell proliferative response to mycobacterial antigens, and efficacy of antituberculosis vaccination with live attenuated Mycobacterium bovis (BCG), 31 production of IFN-g by mycobacteria-specific T cells, 33, 34 as well as production of mycobacteria-specific antibodies. 9, 26 Mouse MHC complex contains several genes that participate in processing and presentation of antigenic peptides to cytokine-producing and cytotoxic T cells. Besides, TNF-a, a cytokine that plays a major role in macrophage-mediated control of MTB and is essential for formation and maintenance of tuberculosis granulomas, 35 is also encoded within the MHC complex. Recently, a coding mutation in TNF-a leader peptide sequence has been found in I/St mouse strain that is highly susceptible to tuberculosis. This mutation affects TNF-a processing and causes higher secretion levels of soluble TNF-a in the I/St mice. 36 Thus, several polymorphic genes within MHC may potentially contribute to critical steps of tuberculosis pathogenesis. In our studies, homozygosity for the B6-derived allele on chromosome 17 conferred significantly higher degree of resistance to tuberculosis in terms of survival (w 2 ¼ 21.17, Po0.0001). To directly examine the likely possibility that polymorphisms at one or more genes encoded within the mouse MHC are responsible for the effect of the chromosome 17 locus, we compared a pair of the MHC congenic strains C57BL/10J (B10, H-2 b ) and C57BL.BR (B10.BR, H-2 k ) for their susceptibility to tuberculosis (Figure 2e) . The B10 mice are closely related to B6 inbred mouse strain and in our model the tuberculosis resistance of B10 mice is similar to that of the B6 mice. The B10.BR is a congenic strain that carries H-2 k haplotype (identical to the H-2 haplotype carried by C3H) on a B10 genetic background. As shown in Figure 2e, Figure 2d) , and of the H-2 congenic mouse strains (Figure 2e ) suggested to us that the H-2 b haplotype did not affect mouse survival at an early stage of tuberculosis infection. To further address this issue, we analyzed contribution of the chromosome 17 locus to survival in mice that succumbed to infection before and after 100 days separately. The survival of the B6 allele homozygous mice was significantly higher in the long-term survivors group (w 2 ¼ 17.2, df ¼ 2, P ¼ 0.0002). Meanwhile, the effect of the B6 allele at this locus in a group of mice that survived for less than 100 days was not significant (w 2 ¼ 2.97, P ¼ 0.23). Thus, homozygosity for the B6-derived allele at the chromosome 17 locus conferred an advantage during chronic stage of tuberculosis infection.
Studies by Kamath et al. demonstrated that the H-2 locus has a profound effect on the antigen-specific CD4 þ -T-cell response after the M. tuberculosis infection in terms of generation and recruitment of activated T cells to the infected lung and production of IFN-g by the MTB-specific T cells after stimulation with mycobacterial antigens. However on the susceptible C3H background, the effect of the H-2 b allele on survival after infection with MTB was negligible. 34 Our data are in agreement with findings of Kamath et al. in that the H-2-encoded polymorphism(s) is not a major determinant of extreme susceptibility of C3HeB/FeJ to tuberculosis. Indeed, if a major effect of the H-2 locus is on activation of MTBspecific IFN-g producing Th1 cells, as suggested by Kamath et al., it is reasonable to expect that the overall impact of MHC on host resistance would depend on epistatic interactions with other polymorphic gene(s) that determine macrophage responsiveness to the Th1-mediated activation. Indeed, we have found that macrophages that carry the C3H-derived susceptible allele at the sst1 locus, responded to activation by the MTBspecific T cells less efficiently (Rojas, unpublished observation). Thus, contribution of the MHC polymorphisms to pathogenesis of tuberculosis in our model is significant, yet ancillary, meanwhile other polymorphic genes mediate host resistance at the initial stages of the infection, perhaps, via control of mechanisms of innate immunity.
Chromosome 7 and 15 loci
The tuberculosis resistance loci on chromosomes 7 and 15 appeared to act roughly independently and additively. The survival of the F2 hybrids that were homozygous for the B6-derived alleles at the D7Mit194 and D15Mit239 markers (MST ¼ 137 days) was two-fold longer as compared to their littermates that were homozygous for the C3H-derived alleles at both loci (MST ¼ 68 days) (Figure 2f) , with mice homozygous at only one of the two loci showing intermediate levels of survival. We confirmed these two loci in an independent experiment using a progeny of backcross of (B6 Â C3H.B6-sst1)F1 on the C3H.B6-sst1 genetic background (total of 85 males), in which all progeny were homozygous for the sst1 resistant allele. In this population, TTD was normally distributed (MST ¼ 144 days) and typing of the candidate intervals on chromosome 7 and 15 loci showed a significant replication of the same linkage (chr7: Z ¼ 3.8, Po0.0001; chr15: Z ¼ 2.7, Po0.005) and again demonstrated additivity (Figure 2g ). The MST of subpopulation of mice that were heterozygous at both D7Mit194 and D15Mit239 markers was 171 days, as compared to 108 days in mice that were homozygous for the C3H alleles at both loci.
Our data suggest that the effects of the chromosome 12 and 17 loci (likely Igh and H-2) represent differences in acquired immunity and affect long-term survival after tuberculosis infection. The Ipr1 gene encoded within the sst1 locus was shown to mediate innate immunity to MTB and was especially important for control of MTB multiplication in the lungs.
14 Meanwhile, mechanisms of host resistance mediated by the chromosome 7 and chromosome 15 loci are currently unknown. To test whether the new loci might affect early course of tuberculosis infection in our model, we compared the rate of MTB growth in the organs of the sst1 R C3H.B6-sst1 and B6 mice within the first 42 days after systemic i.v. infection. The MTB bacterial loads in lungs, spleens and livers of the C57BL/6J (B6) parental mice were significantly lower than that of the sst1 R congenic C3H.B6-sst1 mice as early as 21 days post i.v. infection (Figure 3a) , and the difference was even more pronounced at 42 days ( Figure 3b , the sst1 susceptible C3H mice succumbed to infection before the 6th week after i.v. infection with MTB). Thus, as opposed to a relatively lung-specific effect of the sst1 locus, the effect of other B6-derived loci on MTB multiplication within the first 21-42 days postinfection was systemic.
The C3H and B6 inbred mouse strains carry the resistant and susceptible alleles of the Slc11a1 (formerly Nramp1) gene, respectively. This gene is known to control macrophage-mediated mechanism of natural host resistance to a number of intracellular parasites including several species of mycobacteria.
15,37 Therefore, we considered this gene a potential candidate, although, North et al. have previously shown that the Slc11a1 inactivation did not confer increased susceptibility to systemic and airborn infection with virulent strain of MTB in mice of 129/Sv genetic background. 38 In view of the fact that in human populations certain alleles of NRAMP1 were associated with tuberculosis susceptibility, 39, 40 we hypothesized that proximity of the Ipr1 might mask the effect of the Slc11a1 gene in inbred mouse strains and, therefore, wished to test the Slc11a1 contribution to better control of MTB in the absence of the Ipr1 gene expression. Since the Slc11a1 gene is located approximately 10 cM upstream of the sst1 locus on mouse chromosome 1, we generated congenic mouse strains on B6 genetic background that carry either a large C3H-derived segment of chromosome 1 encompassing both the Slc11a1 gene and the sst1 locus (B6.C3H-Slc11a1,sst1), or a smaller C3H-derived segment that only encompasses the sst1 locus (B6.C3H-sst1, Table 2 ). Both congenic strains carry the C3HeB/FeJ-derived sst1 locus and do not express the Ipr1 gene. The B6.C3H-Slc11a1,sst1 carries the C3H-derived resistant allele of Slc11a1, while the B6.C3H-sst1 carries the B6-derived susceptible allele of this gene and, therefore, does not express a functional Slc11a1 protein. 41 Within the first 21-42 days after i.v. infection with MTB, the bacterial loads in the organs of the B6.C3H-Slc11a1,sst1 and B6.C3H-sst1 mice were similar to that of the parental B6 mice (Figure 3c and d,  respectively) , indicating that greater ability to control early multiplication of MTB of the B6 mice was both Nramp1-and sst1-independent. Multiplication of MTB in the lungs after aerosol infection with a low dose of TB within the first 21 days of infection was also unaffected by either the sst1 or the Nramp1 polymorphisms (Figure 3f) . Meanwhile, the bacterial loads in the lungs at 84 days (12 weeks, Figure 3f ), as well as survival after the aerosol infection (Figure 3e ), were significantly influenced by the sst1, but not the Slc11a1, polymorphism. Our data indicate that although both the Nramp1 and the Ipr1 genes control innate mechanisms of host resistance to intracellular pathogens, neither of them was capable of controlling MTB replication at the initial stage after either systemic or respiratory infection with MTB. However, we have shown that additional B6-derived, yet unknown, resistance loci control MTB multiplication at earlier steps of tuberculosis progression (Figure 3a and b) , chromosome 7 and 15 loci being potential candidates. The chromosome 7 locus has been also identified in a cross of B6 (resistant) and DBA/2 (susceptible) mice using both i.v. and aerosol challenge with MTB. 42, 43 Position of peaks on the chromosome 7 found in our studies was almost identical, suggesting, firstly, that this locus plays an important role in pathogenesis of tuberculosis infection irrespective of route of the pathogen entry and, secondly, that this locus may represent an ancestral polymorphism shared in common between the C3H and DBA/2 inbred strains. This indicates that some of the genetic polymorphisms within those common loci are likely to be ancestral, that is, naturally arising in the wild and pre-existing in mice used for the generation of inbred strains. By contrast, lack of the Ipr1 gene expression in the sst1-susceptible C3HeB/FeJ substrain of C3H represented a de novo mutation 14 showing, as one might expect for a complex phenotype, that both novel, rare as well as ancestral, common polymorphisms contribute to the genetic basis of host resistance to tuberculosis, even in a simplified mouse model.
In immunocompetent individuals, which most human tuberculosis patients are, it seems unlikely that a single gene would be a major determinant of host susceptibility as functional polymorphisms in many genes are expected to affect innate and adaptive immunity. 44, 45 In theory, understanding the causal genetic differences among susceptible and resistant individuals and populations and revealing genetic interactions, which contribute to the trajectory of the disease, would provide a significant insight into mechanisms of pathogenesis and lead to better understanding of successful pathogen strategy in the susceptible host. It is a necessary step on a path leading to rational design of novel diagnostic tools, as well as more effective preventive and therapeutic interventions. However, complex interactions and hierarchy of different mechanisms of immunity during chronic tuberculosis infection in humans are difficult to characterize. Mouse model, which allows control of environmental variation and the testing of specific defects in anti-tuberculosis immunity attributable to each genetic locus in isolation, as well as in combinations, will continue to provide an important experimental approach for elucidating complex genetic architecture of host resistance to tuberculosis.
Materials and methods

Animals
C3HeB/FeJ and C57BL/6J mice were obtained from The Jackson Laboratory (Bar Harbor, Maine, USA). The C3H.B6-sst1 and the B6.C3H-sst1 mouse strains were generated in our laboratory by introgression of an approximately 20 cM interval of chromosome 1 encompassing the mouse tuberculosis susceptibility locus sst1 on the opposite genetic background using 10 backcrosses. In both strains, recombination event between 43 and 49 cM that separated the Slc11a1 gene (formerly known as Nramp1) from the sst1 locus. Abbreviations used for the congenic inbred strains and their genetic composition are presented in Table 1 . Mice were housed under specific-pathogen-free conditions in barrier animal facilities at the Harvard Medical School and provided autoclaved chow and water ad libitum. Moribund mice were humanely killed. TTD experiments were performed with the full knowledge and approval of the Standing Committee on Animals at Harvard Medical School (Protocol # 03000).
Genotyping DNA was isolated from the tail tips by standard procedure. 46 Genotyping for simple sequence length polymorphism markers polymorphic between C57BL and C3H was performed by PCR with pairs of oligonucleotide primers (Mouse MapPairs) Bacteria M. tuberculosis (Erdman strain; Trudeau Institute, Saranac Lake, NY, USA) was passed through mice, grown in Dubos oleic albumin complex-enriched Middlebrook 7H9 liquid medium (Difco) containing 0.05% Tween-80 in roller bottles, pelleted by centrifugation (800 g for 10 min), and resuspended in PBS containing 0.05% Tween-80 (PBS-Tween-80). Glycerol was added to a final concentration of 10%, and the bacterial suspension was aliquoted, frozen and stored at À801C. Viable bacterial counts were determined by plating serial 10-fold dilutions on Middlebrook 7H10 (Difco) agar plates.
Infection
An aliquot of M. tuberculosis was thawed, pre-diluted 10 Â in phosphate-buffered saline (PBS) containing 0.05% Tween-80, and sonicated for 10 s in a cup horn sonicator. For i.v. infection bacteria were diluted by PBS containing 0.05% Tween-80. Mice were i.v. infected via tail vein with 20-100 Â 10 3 live bacilli in a final volume of 100 ml. To enumerate MTB in the organs of the infected animals, three to four mice per time point were used, and each experiment was performed at least twice. Mice were killed using halothane anesthesia. Organs were homogenized in PBS containing 0.05% Tween-80 and serial 10-fold dilutions were plated on 7H10 agar enriched with 10% OADC (Difco, MI, USA). Plates were incubated at 371C and colonies were enumerated after 21-28 days.
Histopatholgy
Frozen sections of lungs were fixed with ice-cold acetone for 10 min and air dried. Staining was performed using B220-specific antibodied (Pharmingen, CA, USA) and peroxidase-labelled secondary antibodies followed by incubation with DAB substrate (Pierce, Rockford, IL, USA).
Auramine/Rhodamine staining Identification of acid-fast bacilli (AFB) was performed on aceton-fixed tissue sections using auramine/rhodamine dye (0.1% Auramine O, 0.01%, Rhodamine B (Sigma, MO, USA) in H 2 O) for 20 min at room temperature in the dark, followed by destaining with 3% HCl in 70% EtOH and counterstained in Mayer's Hematoxylin (VWR).
Statistical analysis
Bacterial loads and cell populations in tuberculosis granulomas of MTB-infected mice were compared using t-test (GraphPad Prizm, version 3.0). Results are presented as the mean7s.d. A threshold for statistical significance was Po0.05. Analysis of survival was performed using GraphPad Prizm (Version 3.0) software (GraphPad software, San Diego, CA, USA). Survial fractions were calculated using Kaplan-Meier method. The survival curves shown in Results are Kaplan-Meier plots. Survival curves stratified by genotype were plotted by using Prizm. The log-rank test was used to test differences between survival curves.
Linkage analysis
Analysis of linkage of survival phenotypes to autosomal loci was performed by using the Mapmaker/SURVIVOR extension of MAPMAKER as described in Symons et al. 17 This software computes LOD scores under the Cox proportional hazards model by using a variant of the expectation maximization algorithm using Monte Carlo simulation. Mapmaker/SURVIVOR is available from MJD at mjdaly@genome.wi.mit.edu.
